PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-546

  1. 572 Posts.
    lightbulb Created with Sketch. 55
    PAR seems to only have patents regarding BMEL's associated with OA - this one isn't "targeting" that - so doesn't look like it on face value.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.